Cover Image

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jessica L. Meades, Marcella Bassetto, Marius C. Staiculescu, Gayathri Swaminath, Samuel J. Fountain
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
by: Marta Lopez‐Balastegui, et al.
Published: (2024)

A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors
by: Simon Miguel M. Lopez, et al.
Published: (2025)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
by: H. Ongun Onaran, et al.
Published: (2024)

Characterisation of neurogenic lipolytic responses in white adipose tissue ex vivo
by: Kayleigh E. Goddard, et al.
Published: (2025)

Autocrine activation of P2X7 receptors mediates catecholamine secretion in chromaffin cells
by: María Constanza Maldifassi, et al.
Published: (2024)

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease
by: Weicong Zhang, et al.
Published: (2024)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
by: Rolien Bosch, et al.
Published: (2024)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy
by: Jaideep Kesavan, et al.
Published: (2025)

P2Y14 receptor activation of platelets induces Ca2+ mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y1 receptors
by: Md Monir Hossain, et al.
Published: (2025)

Ethosuximide: Subunit‐ and Gβγ‐dependent blocker and reporter of allosteric changes in GIRK channels
by: Boris Shalomov, et al.
Published: (2025)

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs
by: Ian Sayers, et al.
Published: (2024)

7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction
by: Ju‐Ying Tsai, et al.
Published: (2025)

Extracellular ATP inhibits excitatory synaptic input on parvalbumin positive interneurons and attenuates gamma oscillations via P2X4 receptors
by: Florian Wildner, et al.
Published: (2024)

Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities
by: Linda J. Flammer, et al.
Published: (2024)

Ligand bias and inverse agonism on 5‐HT2A receptor‐mediated modulation of G protein activity in post‐mortem human brain
by: Itziar Muneta‐Arrate, et al.
Published: (2024)

Role for the liver X receptor agonist 22‐ketositosterol in preventing disease progression in an Alzheimer's disease mouse model
by: Nikita Martens, et al.
Published: (2025)

Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum
by: Jieling Cai, et al.
Published: (2024)

Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription
by: Patrick G. Schweickert, et al.
Published: (2025)

Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice
by: Michael Fleischer, et al.
Published: (2024)

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
by: Simar Singh, et al.
Published: (2024)

The potential for biased signalling in the P2Y receptor family of GPCRs
by: Claudia M. Sisk, et al.
Published: (2025)

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor
by: Zoe Tasma, et al.
Published: (2024)

Inhibition of sphingosine‐1‐phosphate receptor‐2 attenuates chronic gastritis via blocking nuclear translocation of S1P 2 receptors in epithelial cells
by: Ke‐Qin Li, et al.
Published: (2025)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
by: Luping Liu, et al.
Published: (2026)

Structural bases for stoichiometry‐selective calcium potentiation of a neuronal nicotinic receptor
by: Simone Mazzaferro, et al.
Published: (2024)

Radiprodil, a selective GluN2B negative allosteric modulator, rescues audiogenic seizures in mice carrying the GluN2A(N615S) mutation
by: Ilaria Bertocchi, et al.
Published: (2024)

Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge
by: Lærke Smidt Gasbjerg, et al.
Published: (2024)

The activated caveolin‐3/μ‐opioid receptor complex drives morphine‐induced rescue therapy in failing hearts
by: Chengxiao Guo, et al.
Published: (2024)

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir
by: Mohamed Zamzamy, et al.
Published: (2025)

Neurokinin‐1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic mice
by: Alexander Widiapradja, et al.
Published: (2026)

Model‐informed dose selection for an investigational human epidermal growth factor receptor 2 antibody–drug conjugate FS‐1502 in patients with human epidermal growth factor receptor 2‐expressing advanced malignant solid tumours
by: Yi Sun, et al.
Published: (2024)

The role of free‐fatty acid receptors FFA1 and FFA4 in organ fibrosis
by: Priyanka F. Karmokar, et al.
Published: (2026)

Opioid receptors in cardiovascular function
by: Venkatesh Katari, et al.
Published: (2025)

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
by: Elisa Kiselev, et al.
Published: (2025)

Investigation of absorption, metabolism, and excretion of [ 14 C]pruxelutamide (GT0918), an androgen receptor antagonist in humans
by: Yuan‐dong Zheng, et al.
Published: (2025)

Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men
by: Christian Friedrich, et al.
Published: (2024)

SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐catenin
by: Lie Yuan, et al.
Published: (2025)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
by: Takayuki Suzuki, et al.
Published: (2026)

V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
by: Shasha Jin, et al.
Published: (2024)

Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets
by: Kyrylo Pyrshev, et al.
Published: (2024)